Strata Critical Medical (SRTA) Change in Acquisitions & Divestments (2022 - 2026)

Strata Critical Medical (SRTA) has reported Change in Acquisitions & Divestments for 5 consecutive years, with $30.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 71.69% year-over-year to $30.5 million; the TTM figure through Mar 2026 stood at -$7.1 million (down 103.88% YoY), while the FY2025 annual figure was $70.2 million, down 60.46% from the prior year.
• Change in Acquisitions & Divestments advanced to $30.5 million in Q1 2026 per SRTA's latest filing, from -$81.1 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $244.0 million in Q4 2023 and bottomed at -$110.7 million in Q2 2023.
• Historically, Change in Acquisitions & Divestments has averaged $68.3 million across 5 years, with a median of $65.2 million in 2024.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 4.88% in 2025 and fell as far as 224.42% in 2025.
• Strata Critical Medical's Change in Acquisitions & Divestments stood at $208.7 million in 2022, then advanced by 16.92% to $244.0 million in 2023, then plunged by 96.11% to $9.5 million in 2024, then tumbled by 954.07% to -$81.1 million in 2025, then surged by 137.59% to $30.5 million in 2026.
• Business Quant data shows SRTA's Change in Acquisitions & Divestments at $30.5 million in Q1 2026, -$81.1 million in Q3 2025, and $43.6 million in Q2 2025.